Given their role in cancer progression, GDNFs present a promising target for cancer therapy. Inhibitors of GDNF signaling pathways are currently being explored as potential therapeutic agents. For instance, small molecule inhibitors targeting the Ret receptor are under investigation in clinical trials for various cancers.
